Evidence map›Paper›PMID 31466981›Full record

ArticleBMJ case reports2019

Rajiv Prakash Heda, Yolanda Savage, Satheesh P Nair, Rajanshu Verma

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Infection and drug resistance · 2023
    Review
  2. Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis.International journal of molecular sciences · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rajiv Prakash HedaMedicine, UTHSC College of Medicine, Memphis, Tennessee, USA.
Yolanda SavageMicrobiology, Methodist University Hospital, Memphis, Tennessee, USA.
Satheesh P NairTransplant Hepatology, Methodist University Hospital, UTHSC College of Medicine Memphis, Memphis, Tennessee, USA.
Rajanshu VermaTransplant Hepatology, Methodist University Hospital, UTHSC College of Medicine Memphis, Memphis, Tennessee, USA.
Methodist University Hospital · USUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver transplant recipients are immunocompromised by the virtue of being on immunosuppressive agents which put them at risk of having infections from unusual and even multiple concomitant pathogens. We present a case of a 39-year-old man who developed septicaemia with

Indexed as

AdultAllograftsAnti-Bacterial AgentsBiopsyDrainageEnterococcusHematomaHumansImmunocompromised HostImmunosuppressive AgentsInfusions, IntravenousKidneyKidney DiseasesKlebsiella oxytocaLiver CirrhosisLiver TransplantationAnti-Bacterial AgentsImmunosuppressive Agentscirrhosisgastroenterologyinfectious diseasesmalignant disease and immunosuppression

Identifiers

PMID31466981
PMCPMC6721148
OpenAlexW2970813205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.